Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 188.5 | 160.6 | 129.3 | 106.6 |
| Revenue growth | 17.4% | 24.2% | 21.2% | |
| Cost of goods sold | 58.6 | 54.2 | 49.2 | 40.4 |
| Gross profit | 130.0 | 106.4 | 80.1 | 66.2 |
| Gross margin | 68.9% | 66.3% | 62.0% | 62.1% |
| Sales and marketing | 87.9 | 75.9 | 71.3 | 60.8 |
| Research and development | 40.6 | 35.5 | 30.6 | 23.1 |
| General and administrative | 27.7 | 23.2 | 17.8 | 14.2 |
| EBIT | -26.2 | -28.2 | -39.6 | -31.9 |
| EBIT margin | -13.9% | -17.5% | -30.6% | -29.9% |
| Pre-tax income | -25.1 | -31.1 | -40.9 | -32.6 |
| Income taxes | 0.6 | 0.5 | 0.1 | 0.3 |
| Net income | -25.6 | -31.6 | -41.0 | -32.9 |
| Net margin | -13.6% | -19.7% | -31.7% | -30.8% |
| |
| Diluted EPS | ($0.64) | ($1.61) | ($3.24) | ($2.72) |
| Shares outstanding (diluted) | 39.8 | 19.6 | 12.7 | 12.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|